Remove 2025 Remove Data Remove Safety
article thumbnail

GemmaCert: Scientific Study Reveals Major Deviation Between Labelled and Actual CBD Potency in Commercial Products

Puff Puff Post

These results raise safety and efficacy concerns. billion by 2025 growing at an impressive CAGR of 32.6%. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. TEL AVIV, Israel , Feb.

CBD 96
article thumbnail

GemmaCert: Scientific Study Reveals Major Deviation Between Labelled and Actual CBD Potency in Commercial Products

Puff Puff Post

These results raise safety and efficacy concerns. billion by 2025 growing at an impressive CAGR of 32.6%. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. TEL AVIV, Israel , Feb.

CBD 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Oregon proposes only using one type of mushroom for new psilocybin system, and no pills

Cannabis Law Report

But this is the first time Oregonians have been allowed to see some of the nuts and bolts of what some predict could grow into a billion-dollar industry nationally, according to Data Bridge Market Research. Measure 109 called on the state to only license people who have been Oregon residents for at least two years, until 2025.

article thumbnail

MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

article thumbnail

UK: New trade association launching today to lead CBD industry regulation

Cannabis Law Report

The Centre for Medicinal Cannabis’ conference sees the launch of the association, a platform which brings together leading businesses and experts committed to fostering a legally compliant, socially responsible and innovative CBD industry, which puts customers’ safety first. The Association for the Cannabinoid Industry.

CBD 40
article thumbnail

Is CBD safe? FDA Issues Warning Letters to Companies

Puff Puff Post

Many of the safety issues in the report involve the use of CBD without the guidance of a health care professional. This is mainly due to a lack of data. billion, and is expected to grow dramatically by 2025. This includes cases in which CBD products were tested and found to have less Cannabidiol than claimed.

CBD 52
article thumbnail

Where Does The FDA Stand on CBD and CBD Products?

The Joint Blog

organic food market by 2025 is at $70.4 FDA is the government agency that ensures the safety and quality of foods, drugs, cosmetics, and other like products marketed in the United States. CBD Legal and Safety Issues An FDA report presented to the U.S. It has been predicted that the U.S CBD Products and the FDA The U.S.

CBD 33